Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

Volume 3 (2006), Issue 12 (December)

1. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
   Biomaterials, 28(6): 1280-8. [Abstract] [Full-text]
2. Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer.
   Cancer Sci, 97(12): 1366-73. [Abstract] [Full-text]
3. Consideration of serum glucose levels during malignant mediastinal lymph node detection in non-small-cell lung cancer by FDG-PET.
   J Surg Oncol, 94(7): 607-13. [Abstract] [Full-text]
4. Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935.
   J Surg Oncol, 94(7): 599-606. [Abstract] [Full-text]
5. Combinatorial treatment of non-small-cell lung cancers with gefitinib and Ad.mda-7 enhances apoptosis-induction and reverses resistance to a single therapy.
   J Cell Physiol, 210(2): 549-59. [Abstract] [Full-text]
6. High cumulative risk of lung cancer death among smokers and nonsmokers in Central and Eastern Europe.
   Am J Epidemiol, 164(12): 1233-41. [Abstract] [Full-text]
7. Pleuropulmonary involvement in pseudomyxoma peritonei: morphologic assessment and literature review.
   Am J Clin Pathol, 127(1): 135-43. [Abstract] [Full-text]
8. RhoB is frequently downregulated in non-small-cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell line.
   Int J Cancer, 120(3): 543-51. [Abstract] [Full-text]
9. Quality of life and health status of dyads of women with lung cancer and family members.
   Oncol Nurs Forum, 33(6): 1109-16. [Abstract] [Full-text]
10. Serial hypoxia imaging with 99mTc-HL91 SPECT to predict radiotherapy response in nonsmall cell lung cancer.
    Am J Clin Oncol, 29(6): 628-33. [Abstract] [Full-text]
11. A review of vaccine clinical trials for non-small cell lung cancer.
    Expert Opin Biol Ther, 7(1): 89-102. [Abstract] [Full-text]
12. SNIP1 is a candidate modifier of the transcriptional activity of c-Myc on E box-dependent target genes.
    Mol Cell, 24(5): 771-83. [Abstract] [Full-text]
13. 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors.
    Anticancer Drugs, 18(1): 65-78. [Abstract] [Full-text]
14. Lung cancer.
    Radiol Clin North Am, 45(1): 21-43. [Abstract] [Full-text]
15. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.
    N Engl J Med, 355(24): 2542-50. [Abstract] [Full-text]
16. Outcome of treated advanced non-small cell lung cancer with and without central airway obstruction.
    Chest, 130(6): 1803-7. [Abstract] [Full-text]
17. Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men.
    Chest, 130(6): 1796-802. [Abstract] [Full-text]
18. Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study.
    Chest, 130(6): 1791-5. [Abstract] [Full-text]
19. Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status.
    Chest, 130(6): 1784-90. [Abstract] [Full-text]
20. Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice.
    Carcinogenesis, 28(1): 163-73. [Abstract] [Full-text]
21. Prevention of mouse lung tumors and modulation of DNA methylation by combined treatment with budesonide and R115777 (Zarnestra MT).
    Carcinogenesis, 28(1): 124-9. [Abstract] [Full-text]
22. Early manifestations of NNK-induced lung cancer: role of lung immunity in tumor susceptibility.
    Am J Respir Cell Mol Biol, 36(1): 13-9. [Abstract] [Full-text]
23. Expression of aquaporin 3 (AQP3) in normal and neoplastic lung tissues.
    Hum Pathol, 38(1): 171-8. [Abstract] [Full-text]
24. No association between dinucleotide repeat polymorphism in intron 1 of the epidermal growth factor receptor gene EGFR and risk of lung cancer.
    Cancer Genet Cytogenet, 172(1): 29-32. [Abstract] [Full-text]
25. Combined genotoxic effects of radiation and a tobacco-specific nitrosamine in the lung of gpt delta transgenic mice.
    Mutat Res, 626(1): 15-25. [Abstract] [Full-text]
26. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
    J Natl Cancer Inst, 98(24): 1786-94. [Abstract] [Full-text]
27. Solitary pulmonary nodules: detection, characterization, and guidance for further diagnostic workup and treatment.
    AJR Am J Roentgenol, 188(1): 57-68. [Abstract] [Full-text]
28. Dynamic MRI of solitary pulmonary nodules: comparison of enhancement patterns of malignant and benign small peripheral lung lesions.
    AJR Am J Roentgenol, 188(1): 26-36. [Abstract] [Full-text]
29. Neurologic dysfunction after major thoracic surgery in a patient with severe arteriosclerotic disease receiving epidural analgesia.
    Anesth Analg, 104(1): 204-6. [Abstract] [Full-text]
30. Lower extremity paralysis after thoracotomy or thoracic epidural: image first, ask questions later.
    Anesth Analg, 104(1): 201-3. [Abstract] [Full-text]
31. Tumor-suppressive effects of MBP-1 in non-small cell lung cancer cells.
    Cancer Res, 66(24): 11907-12. [Abstract] [Full-text]
32. Human kallikrein 8 protease confers a favorable clinical outcome in non-small cell lung cancer by suppressing tumor cell invasiveness.
    Cancer Res, 66(24): 11763-70. [Abstract] [Full-text]
33. Occupational exposure to crystalline silica and risk of lung cancer: a multicenter case-control study in Europe.
    Epidemiology, 18(1): 36-43. [Abstract] [Full-text]
34. Exposure to diesel and gasoline engine emissions and the risk of lung cancer.
    Am J Epidemiol, 165(1): 53-62. [Abstract] [Full-text]
35. Decreased prevalence of asymptomatic choroidal metastasis in disseminated breast and lung cancer: argument against screening.
    Br J Ophthalmol, 91(1): 74-5. [Abstract] [Full-text]
36. 11C-acetate and 18F-fluorodeoxyglucose positron emission tomography of pulmonary adenocarcinoma.
    Ann Thorac Surg, 83(1): 312-4. [Abstract] [Full-text]
37. Large clear cell tumor of the lung mimicking malignant behavior.
    Ann Thorac Surg, 83(1): 310-2. [Abstract] [Full-text]
38. Lung large cell carcinoma producing granulocyte-colony-stimulating factor.
    Ann Thorac Surg, 83(1): 308-10. [Abstract] [Full-text]
39. Role of surgery in the treatment of primary pulmonary B-cell lymphoma.
    Ann Thorac Surg, 83(1): 236-40. [Abstract] [Full-text]
40. Oligometastatic non-small cell lung cancer: a multidisciplinary approach in the positron emission tomographic scan era.
    Ann Thorac Surg, 83(1): 231-4. [Abstract] [Full-text]
41. Superior vena cava resection for lung and mediastinal malignancies: a single-center experience with 70 cases.
    Ann Thorac Surg, 83(1): 223-9; discussion 229-30. [Abstract] [Full-text]
42. Clinical value of serum cytokeratin 19 fragment and sialyl-Lewis x in non-small cell lung cancer.
    Ann Thorac Surg, 83(1): 216-21. [Abstract] [Full-text]
43. Prognostic significance of a histologic subtype in small adenocarcinoma of the lung: the impact of nonbronchioloalveolar carcinoma components.
    Ann Thorac Surg, 83(1): 209-14. [Abstract] [Full-text]
44. Clinical relevance of intraoperative pleural lavage cytology in non-small cell lung cancer.
    Ann Thorac Surg, 83(1): 204-8. [Abstract] [Full-text]
45. Recurrence patterns in patients with early stage non-small cell lung cancers undergoing positive pleural lavage cytology.
    Ann Thorac Surg, 83(1): 197-202. [Abstract] [Full-text]
46. Tumor and normal tissue motion in the thorax during respiration: Analysis of volumetric and positional variations using 4D CT.
    Int J Radiat Oncol Biol Phys, 67(1): 296-307. [Abstract] [Full-text]
47. Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer.
    Int J Radiat Oncol Biol Phys, 67(1): 187-95. [Abstract] [Full-text]
48. Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis.
    Expert Rev Mol Diagn, 7(1): 77-86. [Abstract] [Full-text]
49. The variation in Fas localization and the changes in Fas expression level upon stimulation with growth factors.
    Biochem Biophys Res Commun, 353(1): 159-63. [Abstract] [Full-text]
50. Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases.
    Int J Radiat Oncol Biol Phys, 67(1): 240-3. [Abstract] [Full-text]
51. Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers.
    Thorax, 62(1): 51-6. [Abstract] [Full-text]
52. Surveillance for the detection of early lung cancer in patients with bronchial dysplasia.
    Thorax, 62(1): 43-50. [Abstract] [Full-text]
53. Gene-environment interactions between smoking and a haplotype of RAI, ASE-1 and ERCC1 polymorphisms among women in relation to risk of lung cancer in a population-based study.
    Cancer Lett, 247(1): 159-65. [Abstract] [Full-text]
54. Application of a methylation gene panel by quantitative PCR for lung cancers.
    Cancer Lett, 247(1): 56-71. [Abstract] [Full-text]

© 2004-2008 Lung Cancer Research Today. All Rights Reserved.